Horsfield N[au] - Search Results

Year	Number of Results
1981	2
1985	1
1986	1
1987	1
1989	1
1991	1
1993	1
1995	2
1996	1
1998	1
2001	2
2002	2
2022	0

1

Pyrazinamide in tuberculosis.

Ormerod LP, Horsfield N. Ormerod LP, et al. Among authors: horsfield n. Lancet. 1981 Dec 19-26;2(8260-61):1417. doi: 10.1016/s0140-6736(81)92826-9. Lancet. 1981. PMID: 6118781 No abstract available.

2

Short course chemotherapy for pulmonary tuberculosis.

Ormerod LP, McCarthy OR, Rudd RM, Horsfield N. Ormerod LP, et al. Among authors: horsfield n. Respir Med. 1991 Jul;85(4):291-4. doi: 10.1016/s0954-6111(06)80099-5. Respir Med. 1991. PMID: 1947365

3

How frequently do endobronchial secondaries occur in an unselected series?

Ormerod LP, Horsfield N, Alani FS. Ormerod LP, et al. Among authors: horsfield n. Respir Med. 1998 Mar;92(3):599-600. doi: 10.1016/s0954-6111(98)90317-1. Respir Med. 1998. PMID: 9692131 Free article.

4

Frequency and type of reactions to antituberculosis drugs: observations in routine treatment.

Ormerod LP, Horsfield N. Ormerod LP, et al. Among authors: horsfield n. Tuber Lung Dis. 1996 Feb;77(1):37-42. doi: 10.1016/s0962-8479(96)90073-8. Tuber Lung Dis. 1996. PMID: 8733412

5

Outcome of the treatment of culture negative tuberculosis (respiratory and non-respiratory): Blackburn 1996-2000.

Ormerod LP, Green RM, Horsfield N. Ormerod LP, et al. Among authors: horsfield n. J Infect. 2002 Aug;45(2):88-9. doi: 10.1053/jinf.2002.1031. J Infect. 2002. PMID: 12217709

6

Etoposide compared with the combination of vincristine, doxorubicin, and cyclophosphamide in the treatment of small cell lung cancer.

McIllmurray MB, Bibby RJ, Taylor BE, Ormerod LP, Edge JR, Wolstenholme RJ, Willey RF, O'Reilly JF, Horsfield N, Johnson CE, et al. McIllmurray MB, et al. Among authors: horsfield n. Thorax. 1989 Mar;44(3):215-9. doi: 10.1136/thx.44.3.215. Thorax. 1989. PMID: 2539655 Free PMC article. Clinical Trial.

7

First use of G-CSF in chlorpromazine-induced agranulocytosis: a report of two cases.

Kendra JR, Rugman FP, Flaherty TA, Myers A, Horsfield N, Barton A, Russell L. Kendra JR, et al. Among authors: horsfield n. Postgrad Med J. 1993 Nov;69(817):885-7. doi: 10.1136/pgmj.69.817.885. Postgrad Med J. 1993. PMID: 7507240 Free PMC article.

8

Short-course antituberculous chemotherapy for pulmonary and pleural disease: 5 years' experience in clinical practice.

Ormerod LP, Horsfield N. Ormerod LP, et al. Among authors: horsfield n. Br J Dis Chest. 1987 Jul;81(3):268-71. doi: 10.1016/0007-0971(87)90160-4. Br J Dis Chest. 1987. PMID: 3663498

9

Can a nine-month regimen be used to treat isoniazid resistant tuberculosis diagnosed after standard treatment is started?

Ormerod LP, Horsfield N, Green RM. Ormerod LP, et al. Among authors: horsfield n. J Infect. 2001 Jan;42(1):1-3. doi: 10.1053/jinf.2000.0773. J Infect. 2001. PMID: 11243745

10

Short-course chemotherapy for tuberculous pleural effusion and culture-negative pulmonary tuberculosis.

Ormerod LP, McCarthy OR, Rudd RM, Horsfield N. Ormerod LP, et al. Among authors: horsfield n. Tuber Lung Dis. 1995 Feb;76(1):25-7. doi: 10.1016/0962-8479(95)90575-8. Tuber Lung Dis. 1995. PMID: 7718842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results